Macrolide antibiotic
This page covers all Macrolide antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Bacterial 50S ribosomal subunit, Bacterial 50S ribosomal subunit (23S rRNA), 50S ribosomal subunit.
Targets
Bacterial 50S ribosomal subunit · Bacterial 50S ribosomal subunit (23S rRNA) · 50S ribosomal subunit
Marketed (20)
- Azithromycin or placebo tablets · Rigshospitalet, Denmark · Infectious Disease; Respiratory/Immunology (in investigational use)
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Administration of Azithromycin on Day 1 · London School of Hygiene and Tropical Medicine · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Intravenous Clarithromycin · University of Athens · Infectious Disease
Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - P.O roxithromycin 150 mg*2/d for 7 days · Western Galilee Hospital-Nahariya · Infectious Disease
Roxithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and bacterial growth. - AzaSite® · Merck Sharp & Dohme LLC · Ophthalmology
AzaSite is an azithromycin ophthalmic suspension that reduces bacterial load and inflammatory mediators in the eye to treat bacterial conjunctivitis and meibomian gland dysfunction. - Clarithromycin (ST14) · National Taiwan University Hospital · Infectious Disease
Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and bacterial growth. - FMS azithromycin tablets · University of Taubate · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Azithromycin 1 gram IV · Thomas Jefferson University · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and stopping bacterial growth. - Azithromycin 3 days · University of Oxford · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - mass treatment with oral azithromycin · University of California, San Francisco · Infectious Disease / Public Health
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, and in mass treatment campaigns is used to reduce transmission of infectious diseases at the population level. - azithromycin (AZ) · Pfizer · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and stopping bacterial growth. - Azithromycin 1gm · Ain Shams Maternity Hospital · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth. - IV azithromycin · Pfizer · Infectious Disease
IV azithromycin is a macrolide antibiotic that binds to bacterial ribosomal RNA and inhibits protein synthesis, killing susceptible bacteria. - Azithromycin Ophthalmic Solution, 1% · Merck Sharp & Dohme LLC · Ophthalmology / Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby killing or stopping the growth of susceptible bacteria. - AzaSite Eye Drops · Merck Sharp & Dohme LLC · Ophthalmology
AzaSite is an azithromycin ophthalmic suspension that reduces bacterial load and inflammatory mediators in the eye to treat bacterial conjunctivitis and meibomian gland dysfunction. - Azithropycin according to symptoms · University Hospital, Montpellier · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Erythromycin, Azithromycin , Clarithromycin · Baqiyatallah Medical Sciences University · Infectious Disease
These macrolide antibiotics inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. - QS azithromycin tablets · University of Taubate · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Zmax · Pfizer · Infectious Disease
Zmax (azithromycin extended-release) is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Azithromycin Oral Product · Thomas Jefferson University · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby stopping bacterial growth.
Phase 3 pipeline (16)
- Low Dose Maolactin · RDC Clinical Pty Ltd · Infectious diseases
Low Dose Maolactin is a derivative of erythromycin that works by inhibiting bacterial protein synthesis. - Erythromycin Ointment · National Eye Institute (NEI) · Ophthalmology / Infectious Disease
Erythromycin ointment is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, reducing bacterial growth and infection. - Clarithromycin DST (125 mg) · Grünenthal GmbH · Infectious Disease
Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Clarithromycin DST (250 mg) · Grünenthal GmbH · Infectious Disease
Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - AZM X mg · Celltrion · Infectious diseases
Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. - Azithromycin on Day 1 · Lihir Medical Centre · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and halting bacterial growth. - AZM Group · University of Alabama at Birmingham · Infectious disease
Azithromycin targets bacterial ribosomes to inhibit protein synthesis. - Clarithromycin DST (187.5 mg) · Grünenthal GmbH · Infectious Disease
Clarithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Clarithromycin Syrup (125 mg) · Grünenthal GmbH · Infectious Disease
Clarithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide bond formation and bacterial growth. - erythromycin [Eritex] · Hoffmann-La Roche · Infectious diseases
Erythromycin inhibits protein synthesis by binding to the 50S subunit of the bacterial ribosome. - Standard course macrolide · UMC Utrecht · Infectious disease
Macrolides inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit. - azithromycin sustained release · Pfizer · Infectious diseases
Azithromycin sustained release works by inhibiting bacterial protein synthesis. - azithromycin (Zithromax) · Pfizer · Infectious Disease
Azithromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. - Infex 400 MR · Neutec Ar-Ge San ve Tic A.Ş · Infectious diseases
Infex 400 MR is a macrolide antibiotic that inhibits bacterial protein synthesis. - Azithromycin on Day 8 · Lihir Medical Centre · Infectious Disease
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby stopping bacterial growth. - clarithromycin immediate-release tablets · Abbott · Infectious diseases
Clarithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.
Phase 2 pipeline (3)
- Azithromycin IV · Pfizer · Infectious diseases
Azithromycin IV is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. - Azithromycin Oral Liquid Product · Copenhagen Studies on Asthma in Childhood · Infectious diseases
Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit. - Azithromycin 1 gram · ActivBiotics Pharma, LLC · Infectious diseases
Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.